PMID- 19913849 OWN - NLM STAT- MEDLINE DCOM- 20100611 LR - 20220316 IS - 1532-8600 (Electronic) IS - 0026-0495 (Linking) VI - 59 IP - 6 DP - 2010 Jun TI - Angiopoietin-2 levels in glucose intolerance, hypertension, and metabolic syndrome in Asian Indians (Chennai Urban Rural Epidemiology Study-74). PG - 774-9 LID - 10.1016/j.metabol.2009.09.022 [doi] AB - The aim of the study was to look at the association of angiopoietin-2 (Ang-2) in Asian Indian subjects with different grades of glucose intolerance and in those with hypertension and metabolic syndrome (MS). Three groups were recruited from the Chennai Urban Rural Epidemiology Study, a population-based study in southern India, as follows: group 1, normal glucose tolerance(n = 45); group 2, impaired glucose tolerance (IGT) (n = 45); and group 3, type 2 diabetes mellitus (T2DM) (n = 40). Angiopoietin-2 was estimated by enzyme-linked immunosorbent assay. Hypertension was diagnosed based on medical history, drug treatment of hypertension, and/or if the subjects had systolic blood pressure at least 130 mm Hg and/or diastolic blood pressure at least 85 mm Hg. Metabolic syndrome was defined using modified National Cholesterol Education Program-Adult Treatment Panel III guidelines. Subjects with T2DM had higher age-adjusted Ang-2 values (3741 +/- 1429 pg/mL) compared with subjects with IGT (1907 +/- 855 pg/mL) and normal glucose tolerance (1462 +/- 856 pg/mL) (P for trend < .001). Regression analysis showed that there was a linear increase in mean Ang-2 values with increasing severity of glucose intolerance, even after adjusting for age, sex, and body mass index. Angiopoietin-2 levels were also elevated in subjects with hypertension (P = .004) and in subjects with MS even in the absence of fasting hyperglycemia (P = .011). There was also a linear increase in the mean values of Ang-2 with increase in number of components of MS (P for trend < .001). This study demonstrates that increased levels of Ang-2 are seen in Asian Indian subjects with IGT, T2DM, and hypertension and in subjects with MS even in the absence of fasting hyperglycemia. CI - Copyright 2010 Elsevier Inc. All rights reserved. FAU - Anuradha, Sathish AU - Anuradha S AD - Madras Diabetes Research Foundation & Dr Mohan's Diabetes Specialities Centre, WHO Collaborating Centre for Non-Communicable Diseases Prevention and Control, Gopalapuram, Chennai 600086, India. FAU - Mohan, Viswanathan AU - Mohan V FAU - Gokulakrishnan, Kuppan AU - Gokulakrishnan K FAU - Dixit, Madhulika AU - Dixit M LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20091114 PL - United States TA - Metabolism JT - Metabolism: clinical and experimental JID - 0375267 RN - 0 (Angiopoietin-2) SB - IM MH - Adult MH - Age Factors MH - Angiopoietin-2/*metabolism MH - Anthropometry MH - Diabetes Mellitus, Type 2/epidemiology/metabolism MH - Female MH - Glucose Intolerance/epidemiology/*metabolism MH - Glucose Tolerance Test MH - Humans MH - Hypercholesterolemia/blood/epidemiology MH - Hypertension/epidemiology/*metabolism MH - India/epidemiology MH - Male MH - Metabolic Syndrome/epidemiology/*metabolism MH - Middle Aged MH - Regression Analysis MH - Risk Factors MH - Rural Population MH - Urban Population EDAT- 2009/11/17 06:00 MHDA- 2010/06/12 06:00 CRDT- 2009/11/17 06:00 PHST- 2009/05/20 00:00 [received] PHST- 2009/09/19 00:00 [revised] PHST- 2009/09/22 00:00 [accepted] PHST- 2009/11/17 06:00 [entrez] PHST- 2009/11/17 06:00 [pubmed] PHST- 2010/06/12 06:00 [medline] AID - S0026-0495(09)00412-0 [pii] AID - 10.1016/j.metabol.2009.09.022 [doi] PST - ppublish SO - Metabolism. 2010 Jun;59(6):774-9. doi: 10.1016/j.metabol.2009.09.022. Epub 2009 Nov 14.